Title |
Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma
|
---|---|
Published in |
Multidisciplinary Respiratory Medicine, July 2012
|
DOI | 10.1186/2049-6958-7-13 |
Pubmed ID | |
Authors |
Alessandra Scaparrotta, Sabrina Di Pillo, Marina Attanasi, Daniele Rapino, Anna Cingolani, Nicola Pietro Consilvio, Marcello Verini, Francesco Chiarelli |
Abstract |
International guidelines recommend the use of inhaled corticosteroids (ICSs) as the preferred therapy, with leukotriene receptor antagonists (LTRAs) as an alternative, for the management of persistent asthma in children. Montelukast (MLK) is the first LTRA approved by the Food and Drug Administration for the use in young asthmatic children.Therefore, we performed an analysis of studies that compared the efficacy of MLK versus ICSs. We considered eligible for the inclusion randomized, controlled trials on pediatric populations with Jadad score > 3, with at least 4 weeks of treatment with MLK compared with ICS.Although it is important to recognize that ICSs use is currently the recommended first-line treatment for asthmatic children, MLK can have consistent benefits in controlling asthmatic symptoms and may be an alternative in children unable to use ICSs or suffering from poor growth. On the contrary, low pulmonary function and/or high allergic inflammatory markers require the corticosteroid use. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 3% |
United States | 1 | 3% |
Tunisia | 1 | 3% |
Unknown | 32 | 91% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 7 | 20% |
Student > Ph. D. Student | 5 | 14% |
Professor > Associate Professor | 5 | 14% |
Student > Master | 4 | 11% |
Unspecified | 2 | 6% |
Other | 5 | 14% |
Unknown | 7 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 16 | 46% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 14% |
Unspecified | 2 | 6% |
Biochemistry, Genetics and Molecular Biology | 1 | 3% |
Agricultural and Biological Sciences | 1 | 3% |
Other | 3 | 9% |
Unknown | 7 | 20% |